Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v3.20.2
Condensed Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Net Sales $ 2,501 $ 6,939 $ 6,488 $ 23,922
Cost of Sales 2,800 4,707 7,658 16,336
Increase in inventory reserve 2,400 2,400
Gross profit (loss) (2,699) 2,232 (3,570) 7,586
Operating Expenses        
Sales and marketing 445 707 1,296 2,033
Research and development 489 546 1,309 1,650
General and administrative 1,080 936 3,154 3,209
Total operating expenses 2,014 2,189 5,759 6,892
Income (loss) from operations (4,713) 43 (9,329) 694
Other income (expenses)        
Interest expense and finance costs (11) (14) (46) (34)
Other income (expense), net 1 19 14 26
Total other income (expenses), net (10) 5 (32) (8)
Income (loss) before income taxes (4,723) 48 (9,361) 686
Income tax benefit        
Current (1,484)
Deferred (655)
Total income tax benefit (2,139)
Net income (loss) $ (4,723) $ 48 $ (7,222) $ 686
Net income (loss) per share - basic and diluted $ (0.42) $ 0 $ (0.68) $ 0.07
Weighted average shares outstanding, basic and diluted 11,315,984 10,143,158 10,659,308 10,143,158